Xylazine-Associated Wounds: Clinical Insights, Challenges, and Management Strategies

Sunday, April 27, 2025

8:30 AM – 9:45 AM

Presenter(s)

JD

Joseph D'Orazio, MD

Associate Professor of Emergency Medicine
Cooper Medical School of Rowan University
Philadelphia, Pennsylvania
RJ

Raagini Jawa, MD, MPH, FASAM

Assistant Professor of Medicine
UPMC
Pittsburgh, Pennsylvania
Tehya Johnson, BSN, MSN, AGPCNP-BC

Associate Medical Director of Harm Reduction and Primary Care NP
Boston Health Care for the Homeless Program
Boston, Massachusetts
LR

Lisa Rae, MD, FACS

Associate Professor, Surgery
Lewis KAtz School of Medicine
Philadelphia, Pennsylvania

This session aims to equip healthcare providers with practical knowledge on comprehensive care approaches for managing xylazine-associated wounds across diverse healthcare settings ranging from basic wound care to advanced surgical interventions. Attendees will explore diverse treatment approaches, including harm reduction, multidisciplinary wound care, and advanced surgical techniques. Through case studies and panel discussions, this session will highlight xylazine-associated wound care provided across various settings.

Learning Objectives:

Learners will be able to:

Recognize the current landscape of the fentanyl-xylazine drug supply
Identify common skin and soft tissue manifestations associated with xylazine use
Apply best practices for managing xylazine-associated wounds

Disclosure(s):

Joseph D'Orazio, MD: No financial relationships to disclose

Raagini Jawa, MD, MPH, FASAM: No financial relationships to disclose

Tehya Johnson, BSN, MSN, AGPCNP-BC: No financial relationships to disclose